Uttar Pradesh fights Against COVID-19: Clinical experience sharing

Uttar Pradesh fights Against COVID-19: Clinical experience sharing


01 Hour 30 Mins

English Site

Recorded Webinar


Aperçu du cours

Indian Medical Association Uttar Pradesh and Max Healthcare welcomes you to the recorded live clinical experience sharing webinar on the topic "Uttar Pradesh fights Against COVID-19: Clinical experience sharing".

What was covered:

Module 1: Treating Moderate to severe cases and use of Remdesivir -Speaker: Dr. Ankit Bhatia (13.45)
• Burden of COVID-19--Global COVID-19
• Pathophysiology of COVID-19 discussed (stages and severity)
• Current Management and Supportive Care guidance according to severity of COVID-19 explained
• Management of moderate COVID-19 discussed
• Awake proning and its importance explained
• Management of Severe COVID-19 and importance of early supportive therapy and monitoring discussed
• Acute coinfection treatment and management of hypoxemic respiratory failure and ARDS discussed
• Non-Therapeutic Management of Critical COVID-19 and Prevention of Complications discussed
• Management of Critical COVID-19 in Septic Shock discussed
• COVID-19 Therapies Predicted to Provide Benefit at Different Stages explained
• Investigational therapies-MoHFW protocol (Convalescent Plasma, Tocilizumab and Remdesivir) described with guidelines
• Clinical trails on use of Remdesivir in Covid-19 discussed
• FDA approval of Remdesivir use and guidelines discussed in detail
• Indian context of using Remdesivir explained

Module 2: Complications in COVID-Speaker: Dr. Surya Kant (1.03.00)
• General discussion on virus and spread
• Investigation and management in Covid-19 discussed
• Complications in COVID-19 discussed (most common and less common)
• Respiratory complications discussed (pneumonia, ARDS types and management )
• Cardiovascular complications and their managemnet discussed
• Treatment of septic shock in covid discussed
• Renal and Hepatic (Acute liver injury )complications discussed
• Neurological complications in Covid discussed
• Gastro intestinal manifestation and management discussed
• Disseminated intravascular coagulation (DIC) and its management discussed
• Post intensive care syndrome described in brief
• Prevention of COVID-19 and improving lung health was discussed

Module 3: Question answer session

We thank our sponsors Viatris to make this program possible and we wish you a great learning experience.


Session à venir Du Nov 28, 2020
Au Feb 27, 2021